Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure.
about
The role of the renal afferent and efferent nerve fibers in heart failureRegulation of the renal sympathetic nerves in heart failureThe sympathetic/parasympathetic imbalance in heart failure with reduced ejection fractionWhat can we learn about treating heart failure from the heart's response to acute exercise? Focus on the coronary microcirculationSympathetic nervous system overactivity and its role in the development of cardiovascular diseaseEffects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats.Intracarotid hypertonic sodium chloride differentially modulates sympathetic nerve activity to the heart and kidney.Sensitivity analysis of dynamic biological systems with time-delaysResponse of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failureDecreased adrenoceptor stimulation in heart failure rats reduces NGF expression by cardiac parasympathetic neurons.Altered norepinephrine content and ventricular function in p75NTR-/- mice after myocardial infarction.Abnormal intracellular calcium homeostasis in sympathetic neurons from young prehypertensive rats.Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failureImpact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertensionDischarge properties of cardiac and renal sympathetic nerves and their impaired responses to changes in blood volume in heart failure.Autonomic cardiac innervation: development and adult plasticity.Specific control of sympathetic nerve activity to the mammalian heart and kidney.The role of renal denervation in the treatment of heart failure.Organ selective regulation of sympathetic outflow by the brain Angiotensin system.Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.Renal sympathetic nerves - what have they got to do with cardiovascular disease?Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals.Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization.Role of endothelin-1 in mediating changes in cardiac sympathetic nerve activity in heart failure.The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.The founding of the Howard Florey Institute of Experimental Physiology and Medicine.The role of the paraventricular nucleus of the hypothalamus in the regulation of cardiac and renal sympathetic nerve activity in conscious normal and heart failure sheep.Central exogenous nitric oxide decreases cardiac sympathetic drive and improves baroreflex control of heart rate in ovine heart failure.Ivabradine has a neutral effect on mortality in randomized controlled trials.The low frequency power of heart rate variability is neither a measure of cardiac sympathetic tone nor of baroreflex sensitivity.Tonic arterial chemoreceptor activity contributes to cardiac sympathetic activation in mild ovine heart failure.Arterial baroreceptor reflex control of renal sympathetic nerve activity following chronic myocardial infarction in male, female, and ovariectomized female rats.Alpha-linolenic acid protects against cardiac injury and remodelling induced by beta-adrenergic overstimulation.
P2860
Q26781599-7720B6F1-2F64-4A81-A572-305F46FDBD04Q26782969-4D946D14-B1C6-48F2-AA45-036D82188978Q27008598-A5A44F9C-931B-4F24-9F29-BB8FE7317543Q28083350-95245199-CF5A-4E6C-9A0D-EFEE9D125E9DQ28279754-497991DF-4DA8-4F10-B53B-A32564AB1C83Q31103227-AA730F37-7F03-490C-AE43-6FC2ED76B583Q33704843-2A3FFB0B-4FBE-4E11-BAD0-231078FF4977Q33755571-3154A8C9-5099-4836-906B-E4383E9716C8Q33784327-383122C8-A064-431B-B357-8833E4D160DEQ34173338-F8268E15-43D5-4B1A-B3EA-9D8F29F321C8Q34321222-7D3EE504-6306-434A-BA35-054C71A42D36Q35196498-63D957BE-E6AD-4416-8C2E-36319268F31BQ35822242-ED627A19-FC82-4610-8733-7261E7A2491BQ35834648-2AFD1146-0BDC-4DF6-A4EF-C8D6F244C215Q37186757-6F8672D4-AB92-474C-9E5D-D4D969007D75Q37337578-A9B5CBBE-BCC5-4EF1-BC89-2AF5E1CF04E4Q37496525-BF3F4995-E4F8-4F41-8777-A83BD0D2AE97Q37555769-9ECBBB3E-EC20-42F0-9927-B250D9254209Q37990825-11A6E4B6-EA0C-4CB0-AAF2-6C0E0EC7870AQ38107424-D6CE1BE7-42C9-4DBD-AF2D-84FFA2EF7354Q38241069-B66E3F90-B13A-4D81-A086-1C4E81BCA792Q38248810-36A18387-40E4-46F9-AE1C-B2FBED9A0368Q38341282-1A26D887-1E76-4E4A-8020-914B58D008E3Q38585664-F900DB19-B6BF-44A3-BB42-60CC0A1E14DAQ39212199-DEF7FD58-51BF-4F2E-91E5-C6E1D99637BCQ40430494-16C810DE-3A24-4B3A-9303-82DF90748519Q43235357-56BC1952-E793-4707-A30D-118B439FC768Q43782277-32B083DB-B082-4B9B-984A-05792DFD01AEQ48499256-164D51EE-9604-430A-883F-05D4A2EC34AEQ48779891-3B4F8B1E-C15C-48E7-93AD-2712DF323EDBQ49249173-C7EEBE76-5112-46F0-928F-9F68C12C15CFQ50612122-C664B322-9617-4B3F-BAFF-5062710CE638Q50637940-EDED9BE8-C755-492B-8B47-45CA568F728EQ51023094-806C143B-9CEC-4997-BF0C-EB0B1AA5AE1AQ52660924-D8DC5C4B-92F4-4456-A03B-DEE02C278795
P2860
Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Basis for the preferential act ...... rve activity in heart failure.
@en
Basis for the preferential act ...... rve activity in heart failure.
@nl
type
label
Basis for the preferential act ...... rve activity in heart failure.
@en
Basis for the preferential act ...... rve activity in heart failure.
@nl
prefLabel
Basis for the preferential act ...... rve activity in heart failure.
@en
Basis for the preferential act ...... rve activity in heart failure.
@nl
P2093
P2860
P50
P356
P1476
Basis for the preferential act ...... rve activity in heart failure.
@en
P2093
Clive N May
Michael J McKinley
Robin L Woods
Sally G Hood
P2860
P304
P356
10.1073/PNAS.0811929106
P407
P577
2009-01-09T00:00:00Z